Daewon Pharmaceutical surges over 10% in aftermarket trading
Predicted impact: Low
Oral obesity drug data and a 10% aftermarket jump; drug data already reported in the last 14 days.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.